DBT is a form of cognitive behavioral therapy (CBT) that was first developed in the 1980s by psychologist Marsha Linehan, PhD, at the University of Washington in Seattle, according to the Association ...

Communication is one of the major skills covered in cognitive behavioral therapy. Although therapy is often with an individual, relationship problems are a common focus of treatment. Helping someone ...

Dialectical behavior therapy (DBT) is a structured program of psychotherapy with a strong educational component designed to provide skills for managing intense emotions and negotiating social ...

Zameena Mejia is a freelance writer and content creator based in New York City. She previously wrote about leadership, self-help, mindfulness and wellness for CNBC Make It. Her bylines have also ...

Aversion therapy (AT) is a behavioral therapy that involves repeatedly pairing an undesirable behavior with an unpleasant experience with the goal of discouraging the undesirable behavior. Other names ...

Contingency management (CM) is a behavioral therapy technique that encourages beneficial behaviors by giving rewards or positive reinforcement. CM incentivizes certain behaviors and discourages ...

As if having cancer wasn’t hard enough, up to 50% of patients and survivors also suffer from insomnia or other sleep disturbances, says Eugenie Spiguel, an advanced practice provider at Memorial Sloan ...

Sleep specialist S. Justin Thomas, Ph.D., has grown accustomed to people looking at him as though he is an eight-headed monster. That’s his way of referring to the reaction he gets from patients when ...

Emily Laurence is a journalist, freelance writer and certified health coach living in Raleigh, North Carolina. She specializes in writing about mental health, healthy aging and overall wellness. For ...

If you value independent local news, become a sustainer today. Your gift could help unlock a $1M challenge. Applied Behavior Analysis (ABA) is a type of therapy that can be used to treat a variety of ...

Sustained Benefit of Blinatumomab in Infants With KMT2A-Rearranged ALL: Long-Term Outcomes, Toxicity, and Pharmacokinetics Among N = 300 patients, 74.7% was female, 76.5% was White, and 19.0% was ...